DSM says generics-focused partnering will drive pharma growth
Royal DSM expects its pharma unit to perform better in 2013 driven by a generics and end-of-lifecycle drug-focused partnership strategy.
Archives for February 20, 2013
ATMI: Single Use Bioreactors on the Up, but US Tails Europe
New innovations in single-use bioprocessing systems are being picked up quicker in Europe than in the US, according to ATMI.
ProBioGen in ADCC Enhancement License Deal with Big Pharma
CMO ProBioGen says its GlymaxX ADCC antibody enhancement technology can be adapted to any biomanufacturing cell line and will attract both Big and Small Pharma.